FLUVIRIN (INACTIVATED INFLUENZA VACCINE)
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
14-05-2024
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
A/SINGAPORE686 - LIKE STRAIN (H1N1) A/WUHAN /359/95 (H3N2)-LIKE STRAIN B/BEIJING /184/93-LIKE STRAIN
थमां उपलब्ध:
Chiron Vaccines Limited
फार्मास्यूटिकल फॉर्म:
Suspension for Injection
प्राधिकरण की तारीख:
1998-08-14
उत्पाद विशेषताएं
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Fluvirin, Suspension for injection in pre-filled syringe. [Influenza Vaccine (Surface antigen,
Inactivated) Ph. Eur.]
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Influenza virus surface antigens (haemagglutinin and neuraminidase) propagated in embryonated
chicken eggs, inactivated by betapropiolactone, split by nonoxynol 9 and purified, of strains:
This vaccine complies with the WHO recommendation (northern hemisphere) and EU decision for the
year 2004/2005.
For excipients see 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection in pre-filled syringe
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Prophylaxis of influenza, especially in those who run an increased risk of associated complications.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults and children from 4 years: 0.5 ml.
For children who have not previously been vaccinated, a second dose should be given after an interval
of at least 4 weeks.
Immunisation should be carried out by intramuscular or deep subcutaneous injection.
A/New Caledonia/20/99 (H1N1) - like strain
(A/New Caledonia/20/99 (IVR-116)) Ph. Eur.
15 micrograms** Haemagglutinin
A/Fujian/411/2002(H3N2) – like strain
(A/Wyoming/3/2003 X-147)
15 micrograms** Haemagglutinin
B/Shanghai/361/2002 - like strain
(B/Jiangsu/10/2003)
15 micrograms** Haemagglutinin
per 0.5 ml dose.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 12/04/2007_
_CRN 2035477_
_page number: 1_
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances, to any of the excipients and to eggs, chicken proteins,
betapropiolactone, nonoxynol 9, neomycin, polymyxin, formaldehyde, or thiomersal.
Immunisation shall be postponed in patients with febrile illness or acu
पूरा दस्तावेज़ पढ़ें
